The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Icorvida SR 1.5mg Prolonged-release Tablets

1.5 milligram(s) Prolonged-release tablet

Krka d.d., Novo mestoPA1347/022/001

Main Information

Trade NameIcorvida SR 1.5mg Prolonged-release Tablets
Active SubstancesIndapamide
Strength1.5 milligram(s)
Dosage FormProlonged-release tablet
Licence HolderKrka d.d., Novo mesto
Licence NumberPA1347/022/001

Group Information

ATC CodeC03BA Sulfonamides, plain
C03BA11 indapamide

Status

Authorised/WithdrawnAuthorised
Licence Issued03/02/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back